Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study

Jeanette Doorduijn, GW van Imhoff, Ronnie van der Holt, HC Schouten, MR Schaafsma, MA MacKenzie, JW Baars, MJ Kersten, Elly Lugtenburg, Martin van den Bent, RH Enting, Fokje Spoelstra, P Poortmans, Jacoline Bromberg

Research output: Contribution to journalArticleAcademicpeer-review

10 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)497-503
Number of pages7
JournalHematological Oncology
Issue number4
Publication statusPublished - 2017

Cite this